ModerateCardiovascularChronic heart failure with reduced ejection fractionuk-plab-1
A 76-year-old woman with heart failure with reduced ejection fraction (LVEF 30%) is stable in clinic. She is currently on Ramipril 10 mg once daily and Bisoprolol 5 mg once daily. Her eGFR is 55 mL/min/1.73 m² and potassium 4.6 mmol/L. She is NYHA class II. According to current guidance, which additional drug class should be added to improve prognosis?